PreveCeutical Medical Inc News

Preveceutical Provides Update on Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect

newsfileMay 30 06:00

Preveceutical Announces First Tranche Closing of Private Placement

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that further t

newsfileMay 29 18:11

PreveCeutical Provides Update on Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect t

newsfileMay 16 19:32

PreveCeutical Announces Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed

newsfileMay 2 17:36

PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program

PreveCeutical Medical Inc. (PREV.CSE) said Monday that it has started preparations to accelerate completion of its preclinical dual gene therapy program using its in vitro validated Smart-siRNA sequen

MT NewswiresDec 4, 2023 06:57

PreveCeutical & Endosane Announce Update on Intranasal CBD Application

PreveCeutical Medical Inc. (PREV.CSE) announced Monday that Endosane Pharmaceuticals GmbH will proceed with its research initiative focused on preclinical studies to evaluate the brain delivery charac

MT NewswiresSep 18, 2023 09:25

PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCe

newsfileJun 28, 2023 06:00

PreveCeutical Medical - Sol-Gel and Uses Thereof Patent Update

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2023) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeu

newsfileMay 30, 2023 06:00

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on Apr

newsfileApr 24, 2023 06:07

PreveCeutical Medical Announces Live Interactive Q&A Video Conference

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that Stephe

newsfileApr 20, 2023 06:05

PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveC

newsfileMar 20, 2023 06:03

PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCe

newsfileMar 6, 2023 06:06

PreveCeutical Files Application for D-amino Acid Peptides

Vancouver, British Columbia--(Newsfile Corp. - November 21, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce it has f

newsfileNov 21, 2022 07:10

PreveCeutical Announces Resignation of Board of Director Member

Vancouver, British Columbia--(Newsfile Corp. - September 16, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the resignation of M

newsfileSep 16, 2022 19:05

Appointment of Sachin Nanavati to PreveCeutical's Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the appointment of Mr

newsfileSep 6, 2022 06:10

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Sees Significant Increase in Short Interest

PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Rating) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, a growt

kopsourceJul 29, 2022 10:41

PreveCeutical Enters into Credit Facility Agreement

Vancouver, British Columbia--(Newsfile Corp. - July 22, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has entered into

newsfileJul 22, 2022 15:55

Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacology

Vancouver, British Columbia--(Newsfile Corp. - May 9, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that the Briti

newsfileMay 9, 2022 07:09